Wagner
Chief Financial Officer
biotechnology and pharmaceutical
CANbridge Life Sciences
China
Biography
Dr. Wagner served as the Chief Financial Officer of Pfenex Inc (NYSE MKT: PFNX), where he led the initial public offering for the company, as well as key asset partnering. Prior to Pfenex, Dr. Wagner was responsible for the biotechnology and pharmaceutical investments for Allianz Global Investors (AGI). Before joining AGI, he led Development Licensing for PDL Biopharma. Dr. Wagner also covered the biotechnology sector as a sell-side equity analyst at Lehman Brothers. He holds a Ph.D. in Chemistry from the California Institute of Technology (Caltech) and is a CFA charterholder
Research Interest
pharmaceutical
